DR. MARIA K HOUTCHENS MD
Prescription History 1740262021
Psychiatry & Neurology - Neurology in Brookline, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MARIA K HOUTCHENS MD, an active Neurology specialist practicing in Brookline, MA. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 694 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 102 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Gabapentin | 102 | $18.99▼ below MA avg | ▲ More than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 102 Medicare prescriptions for Gabapentin, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (79). Medicare paid an average of $18.99 per fill, versus $20.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 165 30-Day Fills standardized to 30-day supplies 4,936 Days of Medication total across all patients in 2023 | |||
| Baclofen | 83 | $43.72 | ▲ More than typical |
About Baclofen: Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). Show more ▾ It works by helping to relax the muscles. A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. In 2023, this provider wrote 83 Medicare prescriptions for Baclofen, about 2.4 times the volume of the typical Massachusetts prescriber of this medication (35). Medicare paid an average of $43.72 per fill, versus $34.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 177 30-Day Fills standardized to 30-day supplies 5,308 Days of Medication total across all patients in 2023 | |||
| CopaxoneGlatiramer Acetate | 80 | $6,969.83 | ▲ More than typical |
About Copaxone: This medication is used to treat multiple sclerosis (MS). Show more ▾ It is a protein that is thought to work by preventing your immune system from attacking the nerves in your brain and spinal cord. This effect can decrease the number of periods of disease worsening (relapses) and prevent or delay disability. It is not a cure for MS. A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS. In 2023, this provider wrote 80 Medicare prescriptions for Copaxone, about 3 times the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $6,969.83 per fill, versus $6,835.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 94.4 30-Day Fills standardized to 30-day supplies 2,692 Days of Medication total across all patients in 2023 | |||
| AubagioTeriflunomide | 58 | $10,956.25 | ▲ More than typical |
About Aubagio: This medication is used by adults to treat multiple sclerosis-MS. Show more ▾ It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS. In 2023, this provider wrote 58 Medicare prescriptions for Aubagio, about 1.5 times the volume of the typical Massachusetts prescriber of this medication (38). Medicare paid an average of $10,956.25 per fill, versus $10,116.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66 30-Day Fills standardized to 30-day supplies 1,970 Days of Medication total across all patients in 2023 | |||
| Dalfampridine ErDalfampridine | 47 | $511.07▼ below MA avg | ≈ Typical |
About Dalfampridine Er: Dalfampridine is used to improve walking in people with multiple sclerosis (MS). Show more ▾ It is a potassium channel blocker. It is thought to work by improving nerve conduction. One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. In 2023, this provider wrote 47 Medicare prescriptions for Dalfampridine Er, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (39). Medicare paid an average of $511.07 per fill, versus $554.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2023 | |||
| Teriflunomide | 37 | $3,638.94 | – No State Data |
About Teriflunomide: This medication is used by adults to treat multiple sclerosis-MS. Show more ▾ It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS. In 2023, this provider wrote 37 Medicare prescriptions for Teriflunomide. Medicare paid an average of $3,638.94 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $3,638.94 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,092 Days of Medication total across all patients in 2023 | |||
| Avonex PenInterferon Beta-1a | 35 | $8,535.96 | ▲ More than typical |
About Avonex Pen: This medication is used to treat multiple sclerosis (MS). Show more ▾ Interferon is not a cure for MS, but it may help to slow disease worsening and decrease flare-ups of symptoms (such as balance problems, numbness, or weakness). An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS. In 2023, this provider wrote 35 Medicare prescriptions for Avonex Pen, about 1.8 times the volume of the typical Massachusetts prescriber of this medication (19). Medicare paid an average of $8,535.96 per fill, versus $8,449.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.7 30-Day Fills standardized to 30-day supplies 1,036 Days of Medication total across all patients in 2023 | |||
| Modafinil | 32 | $155.76▼ below MA avg | ▲ More than typical |
About Modafinil: Modafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). Show more ▾ It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Modafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how modafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS. In 2023, this provider wrote 32 Medicare prescriptions for Modafinil, about 1.5 times the volume of the typical Massachusetts prescriber of this medication (21). Medicare paid an average of $155.76 per fill, versus $276.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2023 | |||
| Kesimpta PenOfatumumab | 30 | $11,973.15 | ▼ Less than typical |
About Kesimpta Pen: Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Show more ▾ Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells. In 2023, this provider wrote 30 Medicare prescriptions for Kesimpta Pen, about 73% of the volume of the typical Massachusetts prescriber of this medication (41). Medicare paid an average of $11,973.15 per fill, versus $10,140.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,114 Days of Medication total across all patients in 2023 | |||
| Zolpidem Tartrate | 20 | $7.57▼ below MA avg | ▼ Less than typical |
About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾ If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA. In 2023, this provider wrote 20 Medicare prescriptions for Zolpidem Tartrate, about half the volume of the typical Massachusetts prescriber of this medication (38). Medicare paid an average of $7.57 per fill, versus $7.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Dimethyl Fumarate | 20 | $545.96▼ below MA avg | ▼ Less than typical |
About Dimethyl Fumarate: Dimethyl fumarate is used to treat multiple sclerosis (MS). Show more ▾ It is not a cure for MS. It helps decrease the number of episodes of worsening MS. A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS. In 2023, this provider wrote 20 Medicare prescriptions for Dimethyl Fumarate, about 71% of the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $545.96 per fill, versus $1,950.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Clonazepam | 17 | $10.46 | ▼ Less than typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2023, this provider wrote 17 Medicare prescriptions for Clonazepam, about a third of the volume of the typical Massachusetts prescriber of this medication (60). Medicare paid an average of $10.46 per fill, versus $9.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| FingolimodFingolimod Hcl | 17 | $7,218.37 | – No State Data |
About Fingolimod: This medication is used to treat multiple sclerosis-MS. Show more ▾ It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of worsening and may prevent or delay disability. A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. In 2023, this provider wrote 17 Medicare prescriptions for Fingolimod. Medicare paid an average of $7,218.37 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $7,218.37 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Tramadol Hcl | 17 | $4.67▼ below MA avg | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2023, this provider wrote 17 Medicare prescriptions for Tramadol Hcl, about a third of the volume of the typical Massachusetts prescriber of this medication (43). Medicare paid an average of $4.67 per fill, versus $8.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 17 30-Day Fills standardized to 30-day supplies 154 Days of Medication total across all patients in 2023 | |||
| GilenyaFingolimod Hcl | 16 | $6,895.03▼ below MA avg | ▼ Less than typical |
About Gilenya: This medication is used to treat multiple sclerosis-MS. Show more ▾ It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of worsening and may prevent or delay disability. A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. In 2023, this provider wrote 16 Medicare prescriptions for Gilenya, about 64% of the volume of the typical Massachusetts prescriber of this medication (25). Medicare paid an average of $6,895.03 per fill, versus $10,436.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 16 30-Day Fills standardized to 30-day supplies 447 Days of Medication total across all patients in 2023 | |||
| AmantadineAmantadine Hcl | 14 | $84.00 | ▼ Less than typical |
About Amantadine: Amantadine is used to treat Parkinson's disease, as well as side effects caused by drugs (such as drug-induced extrapyramidal symptoms), chemicals, and other medical conditions. Show more ▾ In these cases, this medication may help to improve your range of motion and ability to exercise. For the treatment of these conditions, amantadine is believed to work by restoring the balance of natural chemicals (neurotransmitters) in the brain. Amantadine is used to prevent or treat a certain type of flu (influenza A). If you have been infected with the flu, this medication may help make your symptoms less severe and shorten the time it will take you to get better. Taking amantadine if you have been or will be exposed to the flu may help to prevent you from getting the flu. This medication is an antiviral that is believed to work by stopping growth of the flu virus. This medication is not a vaccine. To increase the chance that you will not get the flu, it is important to get a flu shot once a year at the beginning of every flu season, if possible. Based on the recommendation from the Centers for Disease Control (CDC) in the US, amantadine should not be used to treat or prevent influenza A because the current influenza A virus in the United States and Canada is resistant to this medication. For more details, talk to your doctor or pharmacist. An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. In 2023, this provider wrote 14 Medicare prescriptions for Amantadine, about half the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $84.00 per fill, versus $68.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 852 Days of Medication total across all patients in 2023 | |||
| MayzentSiponimod | 12 | $9,197.00▼ below MA avg | ▼ Less than typical |
About Mayzent: This medication is used to treat a certain type of multiple sclerosis (relapsing multiple sclerosis-MS). Show more ▾ Siponimod is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of disease worsening (relapses) and may prevent or delay disability. In 2023, this provider wrote 12 Medicare prescriptions for Mayzent, about half the volume of the typical Massachusetts prescriber of this medication (22). Medicare paid an average of $9,197.00 per fill, versus $9,913.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 12 | $476.40▼ below MA avg | ▼ Less than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 12 Medicare prescriptions for Myrbetriq, about a quarter of the volume of the typical Massachusetts prescriber of this medication (55). Medicare paid an average of $476.40 per fill, versus $561.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $62.46 | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 12 Medicare prescriptions for Hydrocodone-Acetaminophen, about a third of the volume of the typical Massachusetts prescriber of this medication (38). Medicare paid an average of $62.46 per fill, versus $20.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 333 Days of Medication total across all patients in 2023 | |||
| Pregabalin | 11 | $84.25 | ▼ Less than typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2023, this provider wrote 11 Medicare prescriptions for Pregabalin, about a third of the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $84.25 per fill, versus $54.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 748 Days of Medication total across all patients in 2023 | |||
| Tizanidine Hcl | 11 | $21.75 | ▼ Less than typical |
About Tizanidine Hcl: This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). Show more ▾ It works by helping to relax the muscles. In 2023, this provider wrote 11 Medicare prescriptions for Tizanidine Hcl, about a third of the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $21.75 per fill, versus $17.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| AmpyraDalfampridine | 11 | $7,884.28 | ▼ Less than typical |
About Ampyra: Dalfampridine is used to improve walking in people with multiple sclerosis (MS). Show more ▾ It is a potassium channel blocker. It is thought to work by improving nerve conduction. One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. In 2023, this provider wrote 11 Medicare prescriptions for Ampyra, about half the volume of the typical Massachusetts prescriber of this medication (26). Medicare paid an average of $7,884.28 per fill, versus $4,223.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. MARIA K HOUTCHENS MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this Brookline, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
